Véronique Leblond
Département d'Hématologie
Hôpital Pitié-Salpétrière
Paris
France
Name/email consistency: high
- Waldenström's macroglobulinemia and bortezomib. Leblond, V. Haematologica (2005)
- Lymphoproliferative disorders after liver transplantation. Leblond, V., Choquet, S. J. Hepatol. (2004)
- Waldenström's macroglobulinemia: prognostic factors and recent therapeutic advances. Leblond, V., Tournilhac, O., Morel, P. Clin. Exp. Med. (2004)
- Identification of prognostic factors in 61 patients with posttransplantation lymphoproliferative disorders. Leblond, V., Dhedin, N., Mamzer Bruneel, M.F., Choquet, S., Hermine, O., Porcher, R., Nguyen Quoc, S., Davi, F., Charlotte, F., Dorent, R., Barrou, B., Vernant, J.P., Raphael, M., Levy, V. J. Clin. Oncol. (2001)
- Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenström macroglobulinemia in first relapse or with primary refractory disease. Leblond, V., Lévy, V., Maloisel, F., Cazin, B., Fermand, J.P., Harousseau, J.L., Remenieras, L., Porcher, R., Gardembas, M., Marit, G., Deconinck, E., Desablens, B., Guilhot, F., Philippe, G., Stamatoullas, A., Guibon, O. Blood (2001)